Sav-on Pharmacy #3739 Durable Medical Equipment & Medical Supplies Location: 105 E Street Rd, Feasterville, Pennsylvania 19053 Phone: (215) 942-4894 |
Giant Pharmacy 6541 Medicare Supplier Location: 176 West Street Road, Feasterville, Pennsylvania 19053 Phone: (215) 876-6649 |
Ascher Health Care Center Durable Medical Equipment & Medical Supplies Location: 1141 Bustleton Pike, Feasterville, Pennsylvania 19053 Phone: (215) 355-2710 |
Cvs Pharmacy # 02524 Durable Medical Equipment & Medical Supplies Location: 298 East Street Road, Feasterville, Pennsylvania 19053 Phone: (215) 942-5141 |
News Archive
In the light of the ongoing novel coronavirus epidemic in China, the US Food and Drug Administration has granted approval of a diagnostic test for use in emergency situations (emergency use authorization or EUA). The viral infection has spread to many different and distant parts of the world, involving over 25,000 people and causing nearly 600 deaths since it started in December 2019.
There is a lesson in this unexpected juxtaposition nevertheless: No nation can safely base its tax and spending plans on inflexible commitments. Political life, both domestic and international, is too unpredictable. Yet U.S. government spending is mostly on autopilot. The government is scheduled to lay out $3.8 trillion this fiscal year -; 70 percent of which will go to mandatory-spending programs, chiefly Social Security, Medicare, Medicaid and interest on the federal debt. Mr. Obama's plan for fiscal 2015 does not change this; it would increase overall spending slightly, paying for it with selected tax increases, while shifting money among priorities here and there. But these tweaks would take place within the same 30 percent of discretionary spending that the current budget contains (3/4).
By analyzing tissues harvested from organ donors, Columbia University Medical Center (CUMC) researchers have created the first ever "atlas" of immune cells in the human body.
Sean Donahue, M.D., Ph.D., a pediatric ophthalmologist at Vanderbilt Medical Center in Nashville Tenn., agrees. "The data used in this paper unfortunately mixes well-conducted clinical trials and weak, poorly conducted and non-controlled studies."
Researchers from the Duke Human Vaccine Institute and Duke University, Durham NC, USA, recently analyzed the D614G mutation in SARS-CoV-2 in the context of a soluble S ectodomain construct. Their study has been published in the preprint server bioRxiv.
› Verified 5 days ago